Avantor Investor Day Presentation Deck

Investment Biopharma 8 R&D/ Innovation in core capabilities to support growth Navantor™ Raw materials capacity Investments in R&D centers (Shanghai, Bridgewater) and new product introductions Increasing raw set materials capacity & adding hydration capabilities Single-use capacity Additional clean room and manufacturing capacity iii Services New biorepository facility in Frankfurt, Germany to support clinical services growth Quality / regulatory Supporting our Biopharma growth within 1-2% CapEx investment model Juu Harmonized Quality Management System (QMS) and quality lab modernization 37

View entire presentation